These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23473421)

  • 1. Posttransplant hypertension: multipathogenic disease process.
    Barbari A
    Exp Clin Transplant; 2013 Apr; 11(2):99-108. PubMed ID: 23473421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic disorders in renal transplant recipients].
    Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of posttransplant hypertension in pediatric kidney transplant recipients: effect on long term allograft survival].
    Hernández-Infante E; García-Martínez C; Beltrán-de-la-Luz S; Reyes-Acevedo R; Romo-Franco L; Delgadillo-Castañeda R; Orozco-Loza I; Chew-Wong A
    Rev Invest Clin; 2010; 62(5):398-405. PubMed ID: 21416727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension, living kidney donors, and transplantation: where are we today?
    Rossi AP; Vella JP
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):154-64. PubMed ID: 25704353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of resistant hypertension in renal transplant patients.
    Arias M; Fernández-Fresnedo G; Gago M; Rodrigo E; Gómez-Alamillo C; Toyos C; Allende N
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv36-8. PubMed ID: 23258809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients.
    Steigerwalt SP; Brar N; Dhungel A; Butcher D; Steigerwalt S; El-Ghouroury M; Provenzano R
    Transplant Proc; 2009 Dec; 41(10):4184-7. PubMed ID: 20005365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension after kidney transplant.
    Mangray M; Vella JP
    Am J Kidney Dis; 2011 Feb; 57(2):331-41. PubMed ID: 21251543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is age associated with the number or types of medications prescribed to renal transplant recipients?
    Chisholm MA; Melroy J; Johnson M; Mulloy LL; Spivey CA
    J Am Geriatr Soc; 2007 Mar; 55(3):389-94. PubMed ID: 17341241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in kidney transplant recipients.
    Ponticelli C; Cucchiari D; Graziani G
    Transpl Int; 2011 Jun; 24(6):523-33. PubMed ID: 21382101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
    Ward HJ
    J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension in kidney transplantation.
    Castillo-Lugo JA; Vergne-Marini P
    Semin Nephrol; 2005 Jul; 25(4):252-60. PubMed ID: 16202698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management strategies for posttransplant hypertension.
    Midtvedt K; Neumayer HH
    Transplantation; 2000 Dec; 70(11 Suppl):SS64-9. PubMed ID: 11152234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in the kidney transplant recipient.
    Wadei HM; Textor SC
    Transplant Rev (Orlando); 2010 Jul; 24(3):105-20. PubMed ID: 20541387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST).
    Kliem V; Fritsche L; Haller H; Suwelack B; Abendroth D; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U; Ulbricht B;
    Transplant Proc; 2005 Apr; 37(3):1597-600. PubMed ID: 15866683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pravastatin treatment on blood pressure regulation after renal transplantation.
    Lopau K; Spindler K; Wanner C
    Kidney Blood Press Res; 2006; 29(6):329-37. PubMed ID: 17124431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in live related renal transplantation.
    Kaul A; Sharm RK; Gupta A; Sinha N; Singh U
    J Assoc Physicians India; 2011 Nov; 59():715-8. PubMed ID: 22616338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
    Małyszko J; Małyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3069-72. PubMed ID: 19857679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.